Integrating AI-guided design with experimental validation for niosome-based drug delivery systems

OBJECTIVE: To develop and experimentally validate an explainable artificial intelligence (AI) framework that extracts formulation rules for niosomal drug delivery systems from published data and delivers them through a decision-support platform. SIGNIFICANCE: Niosome performance depends on many interacting formulation and process variables, and optimization still relies largely on trial-and-error experimentation. Converting existing formulation knowledge into interpretable, experimentally verified rules could make early-stage development faster and less resource-intensive. METHODS: A database of 33 optimized niosomal formulations (approximately 30 drugs, BCS classes I-V) was compiled from peer-reviewed studies. Correlation analysis, XGBoost feature importance, and SHAP were used to relate formulation variables to particle size, entrapment efficiency (EE%), drug release, and release time. The extracted trends were tested experimentally using 17 diclofenac sodium-loaded niosomal formulations prepared by thin-film hydration. The dataset was expanded to 1000 samples using SMOTE to train XGBoost predictive models, which were evaluated on the original formulations and integrated with a Qwen-based large language model. RESULTS: values of 0.97-0.99 on the original formulations, and the resulting Niosome AI Expert platform showed general agreement between predicted and reported outcomes. CONCLUSIONS: Combining machine learning, explainable AI, and experimental verification can convert existing formulation knowledge into a practical decision-support tool that reduces reliance on trial-and-error niosome development.

Authors

Institutions

Publication Details

Journal
Drug Development and Industrial Pharmacy
Published
2026-11-19
DOI
https://doi.org/10.1080/03639045.2026.2761534
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrating AI-guided design with experimental validation for niosome-based drug delivery systems

Rana M.F. Sammour, Yasmein Yaser Salem, Hamzah Dabool, Tasneem Zarzour et al.
2 links
Drug Development and Industrial Pharmacy
Advanced Drug Delivery Systems
article

Integrating AI-guided design with experimental validation for niosome-based drug delivery systems

Rana M.F. Sammour, Yasmein Yaser Salem, Hamzah Dabool, Tasneem Zarzour, Joud Hourani, Ranim Al Rfai, Sara Abdelgawwad
article en

Abstract

OBJECTIVE: To develop and experimentally validate an explainable artificial intelligence (AI) framework that extracts formulation rules for niosomal drug delivery systems from published data and delivers them through a decision-support platform. SIGNIFICANCE: Niosome performance depends on many interacting formulation and process variables, and optimization still relies largely on trial-and-error experimentation. Converting existing formulation knowledge into interpretable, experimentally verified rules could make early-stage development faster and less resource-intensive. METHODS: A database of 33 optimized niosomal formulations (approximately 30 drugs, BCS classes I-V) was compiled from peer-reviewed studies. Correlation analysis, XGBoost feature importance, and SHAP were used to relate formulation variables to particle size, entrapment efficiency (EE%), drug release, and release time. The extracted trends were tested experimentally using 17 diclofenac sodium-loaded niosomal formulations prepared by thin-film hydration. The dataset was expanded to 1000 samples using SMOTE to train XGBoost predictive models, which were evaluated on the original formulations and integrated with a Qwen-based large language model. RESULTS: values of 0.97-0.99 on the original formulations, and the resulting Niosome AI Expert platform showed general agreement between predicted and reported outcomes. CONCLUSIONS: Combining machine learning, explainable AI, and experimental verification can convert existing formulation knowledge into a practical decision-support tool that reduces reliance on trial-and-error niosome development.

Drug Development and Industrial Pharmacy
Dubai Medical College (AE)
Good health and well-being
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon